Targeting of the IL-5 pathway in severe asthma reduces mast cell progenitors
Journal of Allergy and Clinical Immunology · 2025-04 · 155 (4) · 1310-1320
DOI: 10.1016/j.jaci.2024.10.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-04. Verfasst von P Abigail Alvarado-Vazquez und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Asthma, Interleukin-5, Mast Cells, Stem Cells. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Therapies targeting IL-5 or its receptor (IL-5Rα) are currently used to treat patients with severe eosinophilic asthma. OBJECTIVE: We sought to investigate the impact of anti-IL-5 and anti-IL-5Rα biological therapies on mast cells (MCs) and their progenitors. METHODS: Surface IL-5Rα expression was investigated on MCs and their progenitors in mouse lungs and bone marrow and in human lungs and blood. Isolated human MC progenitors cultured in the presence or absence of IL-5 were analyzed in vitro. Circulating MC progenitors were quantified in patients with severe asthma before and after anti-IL-5 (mepolizumab) or anti-IL-5Rα (benralizumab) therapy. Gene expression analysis of MC progenitors was performed before and after anti-IL-5Rα therapy. RESULTS: Approximately 50% of the human primary lung MCs and 30% of the human MC progenitors from individuals with allergic asthma expressed IL-5Rα. In patients with mild to moderate allergic asthma and mice with acute allergic airway inflammation, the fraction of IL-5Rα+ MC progenitors was elevated. In addition, IL-5 promoted the proliferation and/or survival of isolated human MC progenitors. Furthermore, patients with severe asthma from 2 independent cohorts demonstrated a reduction in blood MC progenitors after anti-IL-5 or anti-IL-5Rα treatment. This was associated with improved asthma control as well as a decline in both blood eosinophils and TH2 cells. Finally, the blood MC progenitors remaining after anti-IL-5Rα (benralizumab) treatment exhibited a downregulated expression of genes involved in growth and proliferation. CONCLUSIONS: This study introduces the possibility that the clinical effects of targeting IL-5/IL-5Rα in severe asthma may also involve reduction of MC populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
- University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.
- University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
- Department of Surgical Sciences, Uppsala University, Uppsala University Hospital, Uppsala, Sweden; Department of Cardiothoracic Surgery and Anesthesiology, Uppsala University Hospital, Uppsala, Sweden.
- Clinical Lung and Allergy Research Unit, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Department of Respiratory Medicine and Allergology, Karolinska University Hospital, Solna, Sweden.
- Clinical Lung and Allergy Research Unit, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Department of Respiratory Medicine and Allergology, Karolinska University Hospital, Solna, Sweden; Inte…
Zitieren
APA
Alvarado-Vazquez, P. A., Mendez-Enriquez, E., Salomonsson, M., Kopac, P., Koren, A., Bidovec-Stojkovic, U., Škrgat, S., Simonson, O. E., Yasinska, V., Dahlén, S. E., Pejler, G., Janson, C., Korosec, P., Malinovschi, A., & Hallgren, J. (2025). Targeting of the IL-5 pathway in severe asthma reduces mast cell progenitors. Journal of Allergy and Clinical Immunology, 155(4), 1310-1320. https://doi.org/10.1016/j.jaci.2024.10.025
Vancouver
Alvarado-Vazquez PA, Mendez-Enriquez E, Salomonsson M, Kopac P, Koren A, Bidovec-Stojkovic U, et al. Targeting of the IL-5 pathway in severe asthma reduces mast cell progenitors. Journal of Allergy and Clinical Immunology. 2025;155(4):1310-1320. doi:10.1016/j.jaci.2024.10.025
BibTeX
@article{AlvaradoVazquez2025,
author = {Alvarado-Vazquez, P Abigail and Mendez-Enriquez, Erika and Salomonsson, Maya and Kopac, Peter and Koren, Ana and Bidovec-Stojkovic, Urska and Škrgat, Sabina and Simonson, Oscar E and Yasinska, Valentyna and Dahlén, Sven-Erik and Pejler, Gunnar and Janson, Christer and Korosec, Peter and Malinovschi, Andrei and Hallgren, Jenny},
title = {Targeting of the IL-5 pathway in severe asthma reduces mast cell progenitors},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
volume = {155},
number = {4},
pages = {1310--1320},
doi = {10.1016/j.jaci.2024.10.025}
}
EUVIMED